Flexible-Dose Trial in Early Parkinson's Disease (PD)
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety, tolerability and
pharmacokinetics (PK) of flexible doses of tavapadon in participants with Parkinson's
Disease.